A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Clinical trial NCT05737940 · COMPLETED

Trial details

NCT number: NCT05737940
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Hypertension (World Health Organization Group 2)Heart Failure

Start date: 2023-04-24
Primary completion: 2025-07-15
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.